These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6119967)

  • 1. Stimulated lymphocytes in schizophrenia.
    Hirata-Hibi M; Higashi S; Tachibana T; Watanabe N
    Arch Gen Psychiatry; 1982 Jan; 39(1):82-7. PubMed ID: 6119967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anatomy of the P lymphocyte.
    Hirata-Hibi M; Hayashi K
    Schizophr Res; 1993 Jan; 8(3):257-62. PubMed ID: 8435387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic-treated chronic schizophrenics.
    Monteleone P; Valente B; Maj M; Kemali D
    Biol Psychiatry; 1991 Jul; 30(2):201-4. PubMed ID: 1680471
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in the functional activity of T-lymphocytes after administration of stelazine].
    Androsova LV; Sekirina TP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):87-9. PubMed ID: 1684460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
    Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
    Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients.
    Theodoropoulou S; Spanakos G; Baxevanis CN; Economou M; Gritzapis AD; Papamichail MP; Stefanis CN
    Schizophr Res; 2001 Jan; 47(1):13-25. PubMed ID: 11163541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte subsets in schizophrenic disorders. Relationship with clinical, neuromorphological and treatment variables.
    Masserini C; Vita A; Basile R; Morselli R; Boato P; Peruzzi C; Pugnetti L; Ferrante P; Cazzullo CL
    Schizophr Res; 1990; 3(4):269-75. PubMed ID: 1980614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunity in schizophrenic patients before and during neuroleptic treatment.
    Müller N; Ackenheil M; Hofschuster E; Mempel W; Eckstein R
    Psychiatry Res; 1991 May; 37(2):147-60. PubMed ID: 1678892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytes in schizophrenic patients under therapy: serological, morphological and cell subset findings.
    Mazzarello V; Cecchini A; Fenu G; Rassu M; Dessy LA; Lorettu L; Montella A
    Ital J Anat Embryol; 2004; 109(3):177-88. PubMed ID: 15597918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication effect on lymphocyte morphology in schizophrenia.
    Torrey EF; Upshaw YD; Suddath R
    Schizophr Res; 1989; 2(4-5):385-90. PubMed ID: 2577275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.
    McAllister CG; Rapaport MH; Pickar D; Paul SM
    Arch Gen Psychiatry; 1989 Oct; 46(10):956-7. PubMed ID: 2572208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Schizophrenia and immunity].
    Galinowski A; Levy-Soussan P; Lôo H
    Ann Med Psychol (Paris); 1992; 150(2-3):138-42. PubMed ID: 1364190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Electron-microscopic study of typical lymphocytes and atypical cells of peripheral blood during the treatment of patients with schizophrenia].
    Bonartsev PD; Brusov OS; Morozova MA; Tsutsul'kovskaia MIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(8):54-8. PubMed ID: 19817008
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte subpopulations in peripheral blood from schizophrenic patients.
    Nyland H; Naess A; Lunde H
    Acta Psychiatr Scand; 1980 Apr; 61(4):313-8. PubMed ID: 6969531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drugs result in the formation of immature neutrophil leucocytes in schizophrenic patients.
    Delieu JM; Badawoud M; Williams MA; Horobin RW; Duguid JK
    J Psychopharmacol; 2001 Sep; 15(3):191-4. PubMed ID: 11565627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is dopamine related to immunologic changes in schizophrenic patients?
    Kerepcić I; Bamburac J; Jurin M
    Ann N Y Acad Sci; 1987; 496():737-9. PubMed ID: 2886098
    [No Abstract]   [Full Text] [Related]  

  • 17. T lymphocytes in schizophrenia.
    Coffey CE; Sullivan JL; Rice JR
    Biol Psychiatry; 1983 Jan; 18(1):113-9. PubMed ID: 6131701
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients.
    Parksepp M; Ljubajev Ü; Täht K; Janno S
    Nord J Psychiatry; 2016 Oct; 70(7):498-502. PubMed ID: 27093226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuroleptic reduction in schizophrenic outpatients receiving high doses.
    Leblanc G; Cormier H; Gagné MA; Vaillancourt S
    Can J Psychiatry; 1994 May; 39(4):223-9. PubMed ID: 7913872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical MRI volumes in neuroleptic-naive and treated patients with schizophrenia.
    Gur RE; Maany V; Mozley PD; Swanson C; Bilker W; Gur RC
    Am J Psychiatry; 1998 Dec; 155(12):1711-7. PubMed ID: 9842780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.